- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Chevron Ratings Report.
Holding back the Dow today is Merck (NYSE: MRK), which is lagging the broader Dow index with an 81-cent decline (-1.3%) bringing the stock to $59.94. This single loss is lowering the Dow Jones Industrial Average by 6.13 points or roughly accounting for 7% of the Dow's overall loss. Volume for Merck currently sits at 598,837 shares traded vs. an average daily trading volume of 11.5 million shares.Merck has a market cap of $172.03 billion and is part of the health care sector and drugs industry. Shares are up 7% year-to-date as of Monday's close. The stock's dividend yield sits at 3%. Merck & Co., Inc. provides health care solutions worldwide. TheStreet Ratings rates Merck as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels, expanding profit margins and increase in stock price during the past year. We feel its strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Merck Ratings Report.